Insiders Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 12:47:17 2026-05-15 pm EDT			5-day change	1st Jan Change
6.250 ^USD	-2.19%		-0.48%	-29.14%

May. 07	Vanda Pharmaceuticals Inc., Q1 2026 Earnings Call, May 06, 2026
May. 06	Vanda Pharmaceuticals Inc. Raises Revenue Guidance for the Full-Year 2026	CI

Insiders

Apr. 22	Vanda Pharmaceuticals Inc. Appoints Charles Duncan to Its Board of Directors, Effective April 22, 2026	CI
Apr. 02	Vanda Pharmaceuticals Inc. Announces Resignation of Timothy Williams as Senior Vice President, General Counsel and Secretary, Effective April 10, 2026	CI
Mar. 05	Vanda Pharmaceuticals Insider Sold Shares Worth $1,276,971, According to a Recent SEC Filing	MT
23-03-17	Vanda Pharmaceuticals Inc. Appoints Dr. Tage Honoré to its Board of Directors	CI
22-12-07	Insider Sell: Vanda Pharmaceuticals	MT
22-04-25	H. Thomas Watkins Not Stands for Reelection of Vanda Pharmaceuticals Inc	CI
21-12-02	Insider Sell: Vanda Pharmaceuticals	MT
21-10-08	Vanda Pharmaceuticals Inc. Announces Resignation of Aranthan “Aj” Jones II as the Corporate Affairs and Communications Officer	CI
21-09-17	Insider Sell: Vanda Pharmaceuticals	MT
21-09-13	Insider Sell: Vanda Pharmaceuticals	MT
21-07-27	Insider Trends: 90-Day Insider Buying Trend Scaled Back with Sale of Vanda Pharmaceuticals Shares	MT
20-04-22	Vanda Pharmaceuticals Inc. Announces Resignation of Mihael H. Polymeropoulos as Director	CI
20-03-03	Vanda Pharmaceuticals Inc. Announces Resignation of Gian Piero Reverberi as Senior Vice President and Chief Commercial Officer, Effective as of March 16, 2020	CI
20-02-20	Vanda Pharmaceuticals Inc. Announces Executive Changes, Effective March 15, 2020	CI
20-02-19	Vanda Pharmaceuticals Inc. Announces Board Changes	CI
20-01-21	Vanda Pharmaceuticals Announces Resignation of Gian Piero Reverberi as its Senior Vice President, Chief Commercial Officer, Effective March 16, 2020	CI
19-11-06	Vanda Pharmaceuticals Inc. Hires Scott L. Howell as Its Chief People Officer	CI
19-10-28	Vanda Pharmaceuticals Inc. Appoints Anne Sempowski Ward to Board of Directors	CI
19-08-21	Vanda Pharmaceuticals Announces Management Appointments	CI
19-04-24	Vanda Pharmaceuticals Appoints Phaedra Chrousos to Board of Directors	CI
18-08-13	Vanda Pharmaceuticals Inc. Appoints Timothy Williams as Senior Vice President, General Counsel and Secretary	CI
18-04-25	Vanda Pharmaceuticals Inc. Announces Retirement of Kenneth M. Bate from the Board of Directors	CI
18-04-23	Vanda Pharmaceuticals Inc Announces Resignation of Richard L. Gulino as Senior Vice President, General Counsel and Secretary, Effective May 2, 2018	CI
17-03-13	Paolo Baroldi Notifies His Resignation as Chief Medical Officer of Vanda Pharmaceuticals Inc., Effective March 22, 2017	CI
16-03-25	Vanda Pharmaceuticals, Inc. Announces Howard H. Pien Not Stand to Re-Elect as Director	CI